XML 32 R21.htm IDEA: XBRL DOCUMENT v3.25.3
Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2025
Fair Value Measurements [Abstract]  
Schedule of Company’s Assets that are Measured at Fair Value

The following table presents information about the Company’s assets and liability that are measured at fair value on a recurring basis at September 30, 2025 and December 31, 2024 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.

 

Description  Level  September 30,
2025
   December 31,
2024
 
Assets:           
Restricted funds – held in Trust Account  1   23,950,427    
 
Marketable securities held in Trust Account  1   3,975,960    26,832,298 
Total marketable securities held in Trust Account  1  $27,926,387   $26,832,298 
Liability:             
Promissory note - 2nd amended and restated  3   7,393,329    
 
Schedule of Second Amended and Restated Promissory Note The following table presents the quantitative information regarding market assumptions used in the Level 3 valuation of the second amended and restated promissory note:
   July 29,
2025
   September 16,
2025
   September 30,
2025
 
Estimated deSPAC stock price  $5.76   $3.74   $3.36 
Remaining term   1.7    1.9    1.8 
Volatility   102.4%   102.4%   102.4%
Risk-free rate   3.85%   3.46%   3.55%
Implied probability of successful initial Business Combination   70.0%   73.7%   74.4%
Schedule of Changes in the Fair Value of the Company’s Level 3 Financial Instruments

The following table provides a summary of the changes in the fair value of the Company’s Level 3 financial instruments that are measured at fair value on a recurring basis:

 

   Promissory note -
2nd amended and
restated
 
Fair value at July 29, 2025  $9,964,704 
Additional draws on promissory note   285,000 
Gain on change in fair value of promissory note   (2,075,267)
Fair value at September 16, 2025   8,174,437 
Gain on change in fair value of promissory note   (781,108)
Fair value at September 30, 2025  $7,393,329